Treatment of Childhood T-Lineage Acute Lymphoblastic

http://bloodjournal.hematologylibrary.org/content/91/3/735.full.html Updated information and services can be found at: (434 articles) Review Articles • Articles on similar topics can be found in the following Blood collections http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#repub_requests Information about reproducing this article in parts or in its entirety may be found online at: http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#reprints Information about ordering reprints may be found online at: http://bloodjournal.hematologylibrary.org/site/subscriptions/index.xhtml Information about subscriptions and ASH membership may be found online at:

[1]  Denis R. Miller,et al.  Residential Exposure to Magnetic Fields and Acute Lymphoblastic Leukemia in Children , 1998 .

[2]  H. Sather,et al.  Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer Group. , 1997, Blood.

[3]  W. Evans,et al.  In vivo toxicity, pharmacokinetics, and antileukemic activity of TXU (anti-CD7)-pokeweed antiviral protein immunotoxin. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[4]  H. Sather,et al.  Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: a Children's Cancer Group study. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  H. Sather,et al.  Cellular Expression of Antiapoptotic BCL-2 Oncoprotein in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia: A Children's Cancer Group Study , 1997 .

[6]  M. Minden,et al.  Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of rhombotin-2 (Lmo-2) and Tal-1 (SCL). , 1997, Blood.

[7]  M. Link,et al.  Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia. , 1997, Cancer research.

[8]  Stephen J. Elledge,et al.  Cell Cycle Checkpoints: Preventing an Identity Crisis , 1996, Science.

[9]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[10]  H. Sather,et al.  Improved clinical outcome for children with T-lineage acute lymphoblastic leukemia after contemporary chemotherapy: a Children's Cancer Group Study. , 1996, Leukemia & lymphoma.

[11]  Craig B. Thompson,et al.  Hierarchical Control of Lymphocyte Survival , 1996, Science.

[12]  D. Baltimore,et al.  Dual roles of ATM in the cellular response to radiation and in cell growth control. , 1996, Genes & development.

[13]  D. Baltimore,et al.  Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. , 1996, Genes & development.

[14]  Francis Collins,et al.  Atm-Deficient Mice: A Paradigm of Ataxia Telangiectasia , 1996, Cell.

[15]  F. Alt,et al.  The T Cell Leukemia Oncoprotein SCL/tal-1 Is Essential for Development of All Hematopoietic Lineages , 1996, Cell.

[16]  D. Graves,et al.  Safety of recombinant deoxyribonucleic acid-derived growth hormone: The National Cooperative Growth Study experience. , 1996, The Journal of clinical endocrinology and metabolism.

[17]  F. E. Alexander,et al.  Space-time clustering of childhood leukaemia in Greece: evidence supporting a viral aetiology. , 1996, British Journal of Cancer.

[18]  A. Taylor,et al.  Leukemia and lymphoma in ataxia telangiectasia. , 1996, Blood.

[19]  John Calvin Reed,et al.  Gamma-radiation induces upregulation of Bax protein and apoptosis in radiosensitive cells in vivo. , 1996, Oncogene.

[20]  K. Furusho,et al.  Normal mutation frequencies of somatic cells in patients receiving growth hormone therapy. , 1996, Mutation research.

[21]  H. Cavé,et al.  Deletion mapping indicates that MTS1 is the target of frequent deletions at chromosome 9p21 in paediatric acute lymphoblastic leukaemias , 1996, British journal of haematology.

[22]  R. Pieters,et al.  Clinical and cell biological features related to cellular drug resistance of childhood acute lymphoblastic leukemia cells. , 1995, Leukemia & lymphoma.

[23]  K. Georgopoulos,et al.  A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma , 1995, Cell.

[24]  U. Kees,et al.  HOX11 expression in pediatric acute lymphoblastic leukemia is associated with T-cell phenotype. , 1995, Oncogene.

[25]  H. Seuánez,et al.  Translocation 11;14 in three children with acute lymphoblastic leukemia of T-cell origin. , 1995, Cancer genetics and cytogenetics.

[26]  Y. Hayashi,et al.  Homozygous deletions of p16/MTS1 gene are frequent but mutations are infrequent in childhood T-cell acute lymphoblastic leukemia. , 1995, Blood.

[27]  J. Wilson,et al.  2-Amino-6-methoxypurine arabinoside: an agent for T-cell malignancies. , 1995, Cancer research.

[28]  G. Reaman,et al.  Immunotoxins for treatment of leukemia and lymphoma. , 1995, Leukemia & lymphoma.

[29]  M. Lovett,et al.  A single ataxia telangiectasia gene with a product similar to PI-3 kinase. , 1995, Science.

[30]  D. Grandér,et al.  p15ink4B and p16ink4 gene inactivation in acute lymphocytic leukemia. , 1995, Blood.

[31]  F. Mandelli,et al.  Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features. , 1995, Blood.

[32]  D N Shapiro,et al.  Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4 , 1995, Molecular and cellular biology.

[33]  S. Shurtleff,et al.  Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia. , 1995, Blood.

[34]  G. Redmond,et al.  Relationship of growth hormone deficiency and leukemia. , 1995, The Journal of pediatrics.

[35]  S. Elledge,et al.  p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. , 1995, Genes & development.

[36]  Lawrence A. Donehower,et al.  A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53–deficient mice , 1995, Nature Genetics.

[37]  D. Mason,et al.  Expression of TAL-1 proteins in human tissues. , 1995, Blood.

[38]  C. O'keefe,et al.  Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. , 1994, Genes & development.

[39]  M. Hsiao,et al.  Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness. , 1994, The American journal of pathology.

[40]  I. Pastan,et al.  Anti‐Tac(Fab)‐PE40, a recombinant double‐chain immunotoxin which kills interleukin‐2‐receptor‐bearing cells and induces complete remission in an in vivo tumor model , 1994, International journal of cancer.

[41]  S. Korsmeyer,et al.  Hox11 controls the genesis of the spleen , 1994, Nature.

[42]  R. Gelber,et al.  Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  S. Elledge,et al.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.

[44]  C. Begley,et al.  SCL, the gene implicated in human T-cell leukaemia, is oncogenic in a murine T-lymphocyte cell line. , 1993, Oncogene.

[45]  S. Galiègue‐Zouitina,et al.  Quantitative and qualitative variation of ETS-1 transcripts in hematologic malignancies. , 1993, Leukemia.

[46]  F. Craig,et al.  Phase I trial of a 90-minute infusion of the fusion toxin DAB486IL-2 in hematological cancers. , 1993, Cancer research.

[47]  S. Korsmeyer,et al.  Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death , 1993, Cell.

[48]  J. Kurtzberg,et al.  Efficacy and toxicity of 9-beta-D-arabinofuranosylguanine (araG) as an agent to purge malignant T cells from murine bone marrow: application to an in vivo T-leukemia model. , 1993, Leukemia.

[49]  T. Waldmann,et al.  APO-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia. , 1993, Blood.

[50]  T. Rabbitts,et al.  The HOX11 gene encodes a DNA-binding nuclear transcription factor belonging to a distinct family of homeobox genes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[51]  J. Shuster,et al.  Intensive alternating drug pairs for treatment of high‐risk childhood acute lymphoblastic leukemia. A pediatric oncology group pilot study , 1993, Cancer.

[52]  M. Amylon,et al.  Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group study. , 1993, Blood.

[53]  T. Waldmann,et al.  Cytotoxic activities of recombinant immunotoxins composed of Pseudomonas toxin or diphtheria toxin toward lymphocytes from patients with adult T-cell leukemia. , 1993, Leukemia.

[54]  D. Moore,et al.  Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment. , 1992, Science.

[55]  F. E. Alexander,et al.  Space-time clustering of childhood acute lymphoblastic leukaemia: indirect evidence for a transmissible agent. , 1992, British Journal of Cancer.

[56]  H. Sather,et al.  Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia. , 1992, Blood.

[57]  J. Rowley,et al.  The LCK Gene Is Involved in the t(1;7)(p34;q34) in the T‐Cell Acute Lymphoblastic Leukemia Derived Cell Line, HSB‐2 , 1991, Genes, chromosomes & cancer.

[58]  T. Rabbitts,et al.  HOX11, a homeobox-containing T-cell oncogene on human chromosome 10q24. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[59]  J. Kurtzberg,et al.  PHARMACOLOGIC PURGING OF MALIGNANT T CELLS FROM HUMAN BONE MARROW USING 9‐β‐D‐ARABINOFURANOSYLGUANINE , 1991, Transplantation.

[60]  W. Ludwig,et al.  TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11). , 1991, Oncogene.

[61]  J. Sklar,et al.  Chromosomal translocations joining LCK and TCRB loci in human T cell leukemia , 1991, The Journal of experimental medicine.

[62]  J. Sklar,et al.  TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms , 1991, Cell.

[63]  Denis R. Miller,et al.  Lymphomatous presentation of childhood acute lymphoblastic leukemia. A subgroup at high risk of early treatment failure , 1991, Cancer.

[64]  S. Korsmeyer,et al.  Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia. , 1991, Science.

[65]  F. Davey,et al.  Significance of aberrant immunophenotypes in childhood acute lymphoid leukemia , 1991, Cancer.

[66]  M. Perutz,et al.  The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[67]  K. M. Abraham,et al.  Thymic tumorigenesis induced by overexpression of p56lck. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[68]  T. Rabbitts,et al.  A study of chromosome 11p13 translocations involving TCR beta and TCR delta in human T cell leukaemia. , 1991, Oncogene.

[69]  K. Weinberg,et al.  Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood. , 1991, The New England journal of medicine.

[70]  K. M. Abraham,et al.  Developmental regulation of lck gene expression in T lymphocytes , 1991, The Journal of experimental medicine.

[71]  C. Marshall.  Tumor suppressor genes , 1991, Cell.

[72]  I. Kirsch,et al.  Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity. , 1990, Science.

[73]  A. Bernard,et al.  Comparison of outcome, clinical, laboratory, and immunological features in 164 children and adults with T-ALL. The Groupe d'Etude Immunologique des Leucémies. , 1990, Leukemia.

[74]  A. Carroll,et al.  Coding sequences of the tal-1 gene are disrupted by chromosome translocation in human T cell leukemia , 1990, The Journal of experimental medicine.

[75]  C. Pui,et al.  Biology and Clinical Significance of Cytogenetic Abnormalities in Childhood Acute Lymphoblastic Leukemia , 1990 .

[76]  M. Borowitz,et al.  Favorable prognosis associated with hyperdiploidy in children with acute lymphocytic leukemia correlates with extra chromosome 6. A pediatric oncology group study , 1990, Cancer.

[77]  M. Amylon,et al.  The t(1;14)(p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. , 1990, Blood.

[78]  F. Behm,et al.  Near-triploid and near-tetraploid acute lymphoblastic leukemia of childhood. , 1990, Blood.

[79]  S. Korsmeyer,et al.  The t(10;14)(q24;q11) of T-cell acute lymphoblastic leukemia juxtaposes the delta T-cell receptor with TCL3, a conserved and activated locus at 10q24. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[80]  R. Baer,et al.  The chromosome translocation (11;14)(p13;q11) associated with T cell acute leukemia. Asymmetric diversification of the translocational junctions , 1990, The Journal of experimental medicine.

[81]  T. Waldmann,et al.  The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[82]  W G Hughes,et al.  Unusual immunophenotypes in acute leukaemias: incidence and clinical correlations , 1989, British journal of haematology.

[83]  C. Bloomfield,et al.  Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia. , 1989, Cancer genetics and cytogenetics.

[84]  M. Cleary,et al.  lyl-1, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif , 1989, Cell.

[85]  P. Nowell,et al.  Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[86]  R. Gale,et al.  Acute lymphoblastic leukemia: recent advances in biology and therapy. , 1989, Blood.

[87]  P. Nowell,et al.  Clustering of breakpoints on chromosome 10 in acute T-cell leukemias with the t(10;14) chromosome translocation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[88]  S. Korsmeyer,et al.  The t(11;14)(p15;q11) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger protein , 1989, Molecular and cellular biology.

[89]  T. Waldmann,et al.  Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[90]  Leo Kinlen,et al.  EVIDENCE FOR AN INFECTIVE CAUSE OF CHILDHOOD LEUKAEMIA: COMPARISON OF A SCOTTISH NEW TOWN WITH NUCLEAR REPROCESSING SITES IN BRITAIN , 1988, The Lancet.

[91]  P. Nowell,et al.  Chromosomal translocation in T-cell leukemia line HUT 78 results in a MYC fusion transcript. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[92]  J. Shuster,et al.  Clinical features and outcome in childhood T-cell leukemia-lymphoma according to stage of thymocyte differentiation: a Pediatric Oncology Group Study. , 1988, Blood.

[93]  F. Behm,et al.  Cytogenetics of childhood T-cell leukemia , 1988 .

[94]  H. Sather,et al.  INTENSIVE THERAPY FOR CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKAEMIA AND UNFAVOURABLE PRESENTING FEATURES Early Conclusions of Study CCG-106 by the Childrens Cancer Study Group , 1988, The Lancet.

[95]  P. Nowell,et al.  Sequence analysis of the MYC oncogene involved in the t(8;14)(q24;q11) chromosome translocation in a human leukemia T-cell line indicates that putative regulatory regions are not altered. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[96]  P. Nowell,et al.  Molecular analysis of a t(7;14)(g35;g32) chromosome translocation in a T cell leukemia of a patient with ataxia telangiectasia , 1988, Cell.

[97]  S. Smith,et al.  Chromosomal translocation involving the beta T cell receptor gene in acute leukemia , 1988, The Journal of experimental medicine.

[98]  T. Rabbitts,et al.  The mechanism of chromosomal translocation t(11;14) involving the T‐cell receptor C delta locus on human chromosome 14q11 and a transcribed region of chromosome 11p15. , 1988, The EMBO journal.

[99]  A. Look,et al.  Teniposide plus cytarabine improves outcome in childhood acute lymphoblastic leukemia presenting with a leukocyte count greater than or equal to 100 x 10(9)/L. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[100]  M. Borowitz,et al.  Immunologic and clinicopathologic features of common acute lymphoblastic leukemia antigen‐positive childhood T‐cell leukemia A pediatric oncology group study , 1987, Cancer.

[101]  M. Greaves.  Differentiation-linked leukemogenesis in lymphocytes. , 1986, Science.

[102]  W. Bishai,et al.  Genetic construction, expression, and melanoma-selective cytotoxicity of a diphtheria toxin-related alpha-melanocyte-stimulating hormone fusion protein. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[103]  D. Housman,et al.  Isolation and expression of a complementary DNA that confers multidrug resistance , 1986, Nature.

[104]  W. Wachsman,et al.  HTLV and human leukemia: perspectives 1986. , 1986, Seminars in hematology.

[105]  R. Gelber,et al.  Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. , 1986, The New England journal of medicine.

[106]  A. Look,et al.  Chromosomal translocations play a unique role in influencing prognosis in childhood acute lymphoblastic leukemia. , 1986, Blood.

[107]  A. Bleyer,et al.  Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[108]  S. Raimondi,et al.  A new translocation, t(10;14)(q24;q11), in T cell neoplasia. , 1986, Blood.

[109]  M. Borowitz,et al.  Clinicopathologic aspects of E rosette negative T cell acute lymphocytic leukemia: a Pediatric Oncology Group study. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[110]  M. Borowitz,et al.  Glucocorticoid receptors in immunological subtypes of childhood acute lymphocytic leukemia cells: a Pediatric Oncology Group Study. , 1985, Cancer research.

[111]  E. Giblett.  ADA and PNP Deficiencies: How It All Began , 1985, Annals of the New York Academy of Sciences.

[112]  C. Berard,et al.  Presence of clonal chromosome abnormalities in virtually all cases of acute lymphoblastic leukemia. , 1985, The New England journal of medicine.

[113]  P. Nowell,et al.  Locus of the alpha-chain of the T-cell receptor is split by chromosome translocation in T-cell leukemias. , 1985, Science.

[114]  J. Rowley,et al.  Lymphoblastic leukemia with lymphomatous features associated with abnormalities of the short arm of chromosome 9. , 1985, The New England journal of medicine.

[115]  A. Fridland,et al.  Metabolic basis of arabinonucleoside selectivity for human leukemic T- and B-lymphoblasts. , 1985, Cancer research.

[116]  C. Pui,et al.  Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia. , 1985, Blood.

[117]  H. Valkenburg,et al.  Childhood leukemia and parental occupation. A register-based case-control study. , 1985, American journal of epidemiology.

[118]  D. Martin,et al.  Specific cytotoxicity of arabinosylguanine toward cultured T lymphoblasts. , 1984, The Journal of clinical investigation.

[119]  A. Look,et al.  New chromosomal translocations correlate with specific immunophenotypes of childhood acute lymphoblastic leukemia , 1984, Cell.

[120]  K. Starling,et al.  Modified LSA2-L2 treatment in 53 children with E-rosette-positive T-cell leukemia: results and prognostic factors (a Pediatric Oncology Group Study). , 1982, Blood.

[121]  C. Pui,et al.  Glucocorticoid receptors in childhood acute lymphocytic leukemia. , 1982, Cancer research.

[122]  R. Painter,et al.  Radiosensitivity in ataxia-telangiectasia: a new explanation. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[123]  B. Lange,et al.  Ataxia‐telangiectasia and acute lymphoblastic leukemia , 1980, Cancer.

[124]  B. Dutrillaux,et al.  High frequencies of inversions and translocations of chromosomes 7 and 14 in ataxia telangiectasia. , 1980, Mutation research.

[125]  L. Borella,et al.  Clinical importance of lymphoblasts with T markers in childhood acute leukemia. , 1975, The New England journal of medicine.

[126]  L. Borella,et al.  T‐ and b‐lymphocytes and lymphoblasts in untreated acute lymphocytic leukemia , 1974, Cancer.

[127]  A. George.  The metabolic basis of inherited disease , 1961 .

[128]  D. Wilkinson,et al.  Elf-2, a rhombotin-2 binding ets transcription factor: discovery and potential role in T cell leukemia , 1997, Leukemia.

[129]  D. Arthur,et al.  CD2 antigen expression on leukemic cells as a predictor of event-free survival after chemotherapy for T-lineage acute lymphoblastic leukemia: a Children's Cancer Group study. , 1996, Blood.

[130]  D. Alexander,et al.  The role of intracellular signalling pathways regulating thymocyte and leukemic T cell apoptosis. , 1996, Leukemia.

[131]  C. Pui,et al.  Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[132]  E. Zabarovsky,et al.  Chromosome 13q14 deletions in lymphoid malignancies , 1996 .

[133]  山本 博之.  Two forms of Hox11, a T cell leukemia oncogene, are expressed in fetal spleen but not in primary lymphocytes , 1996 .

[134]  S. Cory.  Regulation of lymphocyte survival by the bcl-2 gene family. , 1995, Annual review of immunology.

[135]  P. Krammer,et al.  Resistance to APO-1 (CD95) induced apoptosis in T-ALL is determined by a BCL-2 independent anti-apoptotic program. , 1995, Leukemia.

[136]  R. Fotedar,et al.  Cell cycle control of DNA replication. , 1995, Progress in cell cycle research.

[137]  I. Su,et al.  Peripheral T-cell lymphoma in childhood: a report of five cases in Taiwan. , 1994, Medical and Pediatric Oncology.

[138]  R. Pieters,et al.  Clinical relevance of in vitro drug resistance testing in childhood acute lymphoblastic leukemia: the state of the art. , 1994, Medical and pediatric oncology.

[139]  G. Hannon,et al.  p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. , 1994, Nature.

[140]  James M. Roberts,et al.  p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. , 1994, Genes & development.

[141]  P. Möller,et al.  APO-1 (CD95) mediated apoptosis in human T-ALL engrafted in SCID mice. , 1994, Leukemia.

[142]  M. Relling,et al.  Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemia. , 1994, Blood.

[143]  F. Alexander.  Viruses, clusters and clustering of childhood leukaemia: a new perspective? , 1993, European journal of cancer.

[144]  James T. Lin,et al.  Decreased polyglutamylation of methotrexate in acute lymphoblastic leukemia blasts in adults compared to children with this disease. , 1993, Leukemia.

[145]  M. Haas,et al.  Role of the p53 tumor suppressor gene in the pathogenesis and in the suppression of acute lymphoblastic T-cell leukemia. , 1992, Leukemia.

[146]  S. Raimondi,et al.  A novel human homeobox gene lies at the chromosome 10 breakpoint in lymphoid neoplasias with chromosomal translocation t(10;14). , 1991, Blood.

[147]  F. Behm,et al.  Clinical and biologic features of childhood T-cell leukemia with the t(11;14). , 1991, Blood.

[148]  J. Shuster,et al.  Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. , 1990, Blood.

[149]  F. Behm,et al.  Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy. , 1990, Blood.

[150]  F. Behm,et al.  Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia. , 1990, Blood.

[151]  F. Uckun,et al.  Immunophenotype-karyotype associations in human acute lymphoblastic leukemia. , 1989, Blood.

[152]  P. Casellas,et al.  Treatment of leukemia patients with T101 ricin A chain immunotoxins. , 1988, Cancer treatment and research.

[153]  H. Sather,et al.  Modified BFM therapy for children with previously untreated acute lymphoblastic leukemia and unfavorable prognostic features. Report of Children's Cancer Study Group Study CCG-193P. , 1988, The American journal of pediatric hematology/oncology.

[154]  F. Berthold,et al.  [Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)]. , 1987, Klinische Padiatrie.

[155]  F. Behm,et al.  7q32-q36 translocations in childhood T cell leukemia: cytogenetic evidence for involvement of the T cell receptor beta-chain gene. , 1987, Blood.

[156]  F. Zintl,et al.  Results of acute lymphoblastic leukemia therapy in childhood with a modified BFM protocol in a multicenter study in the German Democratic Republic. , 1987, Haematology and blood transfusion.

[157]  G. Leverger,et al.  Intermediate-risk childhood acute lymphoblastic leukemias: amsacrine + cytosine arabinoside versus intermediate-dose methotrexate for consolidation, and 6-mercaptopurine + methotrexate + vincristine versus monthly pulses for maintenance. , 1987, Haematology and blood transfusion.

[158]  Walker,et al.  Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. , 1986, Blood.

[159]  J. Pullen,et al.  Clinical and biologic features predict poor prognosis in acute lymphoid leukemias in children and adolescents: a Pediatric Oncology Group review. , 1986, Medical and pediatric oncology.

[160]  D. Williams,et al.  HTLV-I antibodies in childhood leukemia. , 1985, JAMA.

[161]  G. Henze,et al.  Thymic involvement and initial white blood count in childhood acute lymphoblastic leukemia. , 1981, The American journal of pediatric hematology/oncology.